Literature DB >> 30130783

Metamorphosis of Vehicles: Mechanisms and Opportunities.

Christian Surber, Ulrich Knie.   

Abstract

The visibility of a skin condition or dermatosis led to the reasonable assumption that the direct application of a therapeutic remedy to the target tissue holds many advantages. Through centuries, the nomenclature of topical preparations has proliferated and finally been moulded into the compulsory nomenclature of official compendia. In everyday life, many terms have been added and have complicated understanding and communication among and between healthcare professionals and laypersons. A large proportion of marketed topical preparations contain significant amounts of volatile vehicle ingredients that evaporate once they are applied onto the skin, that is, the vehicle format as well as the sum of vehicle ingredients in the primary container are different from the vehicle format and the sum of vehicle ingredients on the skin. This phenomenon and the potential consequences have so far been often ignored by many healthcare professionals and laypersons. To gain a better understanding, this phenomenon has been coined as the metamorphosis of the vehicle. The metamorphosis of the vehicle describes the vehicle (a) in the primary container (primary formulation), (b) during and immediately after application onto the skin (secondary formulation) and (c) after all volatile vehicle ingredients have evaporated from the vehicle on top of the skin (tertiary or residual formulation). The secondary and tertiary formulations may offer increased delivery of cosmetic or pharmaceutical actives. This is achieved by (a) an intended post-application creation of supersaturation of actives in the secondary and tertiary formulations or by (b) physico-chemical triggers such as pH.
© 2018 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30130783     DOI: 10.1159/000489529

Source DB:  PubMed          Journal:  Curr Probl Dermatol        ISSN: 1421-5721


  6 in total

Review 1.  [New developments in topical pharmaceuticals].

Authors:  Johannes Wohlrab
Journal:  Hautarzt       Date:  2019-12       Impact factor: 0.751

2.  Preparation of Topical Itraconazole with Enhanced Skin/Nail Permeability and In Vivo Antifungal Efficacy against Superficial Mycosis.

Authors:  Laxman Subedi; Seung-Yub Song; Saurav Kumar Jha; Sung-Ho Lee; Rudra Pangeni; Kyo-Tan Koo; Beum Joon Kim; Seung-Sik Cho; Jin Woo Park
Journal:  Pharmaceutics       Date:  2021-04-27       Impact factor: 6.321

3.  Assessment of dermal bioavailability: predicting the input function for topical glucocorticoids using stratum corneum sampling.

Authors:  Andrea Pensado; Anita McGrogan; K A Jane White; Annette L Bunge; Richard H Guy; M Begoña Delgado-Charro
Journal:  Drug Deliv Transl Res       Date:  2021-10-01       Impact factor: 4.617

4.  Simultaneous Physico-Mechanical and In Vivo Assessment towards Factual Skin Performance Profile of Topical Polymeric Film-Forming Systems.

Authors:  Mirjana D Timotijević; Tanja Ilić; Snežana Savić; Ivana Pantelić
Journal:  Pharmaceutics       Date:  2022-01-18       Impact factor: 6.321

Review 5.  [Nano is big! : Facts and myths about nanoparticulate UV filters].

Authors:  Christian Surber; James Plautz; Uli Osterwalder
Journal:  Hautarzt       Date:  2022-02-21       Impact factor: 0.751

6.  Preparation of topical bimatoprost with enhanced skin infiltration and in vivo hair regrowth efficacy in androgenic alopecia.

Authors:  Laxman Subedi; Prashant Pandey; Jung-Hyun Shim; Ki-Taek Kim; Seung-Sik Cho; Kyo-Tan Koo; Beum Joon Kim; Jin Woo Park
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.